or
forgot password

    • cancer clinical trials in westminster, MD

    • Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Chronic Myeloid Leukemia
    Adj TC + Herceptin Early Stage Breast Cancer
    Alliance Hematology Oncology P.A.
    Westminster, Maryland 21157
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Alliance Hematology Oncology PA
    Westminster, Maryland 21157
    Breast Cancer
    Pre-op Rectal ChemoRad +/- Cetuximab
    Alliance Hematology Oncology PA
    Westminster, Maryland 21157
    Rectal Cancer
    Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Chronic Myeloid Leukemia
    Phase II Sunitinib Prog Met AIPC
    Alliance Hematology Oncology PA
    Westminster, Maryland 21157
    Metastatic Prostate Cancer
    Prospective Observational Epidemiologic Study of Maraviroc's Safety
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Human Immunodeficiency Virus
    PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Non-small Cell
    Gemzar, Cisp, Sunitinib Urothelial Ca
    Alliance Hematology Oncology PA.
    Westminster, Maryland 21157
    Urothelial Cancer
    Continuing Access To AG- 013736 (A406) For Patients Previously Receiving AG 013736 In Clinical Trials
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Solid Tumors
    Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Renal Cell
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Alliance Hematology Oncology, P.A.
    Westminster, Maryland 21157
    Metastatic Breast Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    Alliance Hematology Oncology, Pa
    Westminster, Maryland 21157
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    Alliance Hematology Oncology, Pa
    Westminster, Maryland 21157
    Multiple Myeloma
    Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Renal Cell, Kidney Neoplasms
    Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms
    A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Breast Neoplasms
    SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Renal Cell
    Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Non-Small-Cell Lung
    Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Thyroid Neoplasms
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Colorectal Neoplasms
    Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Renal Cell
    Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Colorectal Neoplasms
    Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Colorectal Adenoma
    Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Osteoporosis
    Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Neoplasms
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Osteoporosis
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Carroll County Cancer Center
    Westminster, Maryland 21157
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Flavio Kruter, MD, PA
    Westminster, Maryland 21157
    Metastatic Breast Cancer
    Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Non-Small-Cell Lung
    Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
    Alliance Hematology Oncology, PA - Carroll County Cancer Center
    Westminster, Maryland 21157
    Small Cell Lung Cancer
    A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Breast Neoplasms
    Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
    Alliance Hematology Oncology, PA - Carroll County Cancer Center
    Westminster, Maryland 21157
    Small Cell Lung Cancer
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Advanced HIV Infection
    A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Breast Neoplasms
    A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Neoplasms
    A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Non-Small Cell Lung
    Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Pancreatic Ductal
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    Alliance Hematology Oncology, P.A. (Main)
    Westminster, Maryland 21157
    Small Cell Lung Cancer
    PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Non Small Cell Lung
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Alliance Hematology Oncology, Pa
    Westminster, Maryland 21157
    Metastatic Breast Cancer
    Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung
    Study to Evaluate Erlotinib With or Without SNDX-275 in the Treatment of Patients With Advanced NSCLC
    Alliance Hematology Oncology
    Westminster, Maryland
    Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung
    Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Colorectal Neoplasms
    Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Solid Tumor Malignancy, Lymphoid Malignancy (Lymphoma and CLL), Leukemia, Lymphoma
    Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Adenosquamous Cell
    Follow-Up Study for Exubera
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Diabetes Mellitus
    A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis
    Pfizer Investigational Site
    Westminster, Maryland 21157
    Rheumatoid Arthritis